GlassScriptPhysician profile
Charles N Thornton
NPI 1245237171
$1,725.84
in general payments reported to CMS, 2019-2025
23 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $155 · 2021: $266 · 2022: $240 · 2023: $346 · 2024: $212 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $255.71 | 2019-2025 | Rocklatan, Argos |
| Aerie Pharmaceuticals, INC. | $197.44 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $166.62 | 2019-2023 | |
| Abbvie INC. | $166.49 | 2022-2025 | Alphagan P, Lumigan |
| Allergan, INC. | $131.98 | 2019-2022 | |
| Oyster Point Pharma, INC. | $111.67 | 2022-2024 | Tyrvaya, Ryzumvi |
| Ocular Therapeutix, INC. | $102.78 | 2022-2023 | Dextenza |
| Biotissue Holdings INC. | $90.89 | 2022-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $54.32 | 2019-2021 | |
| Sandoz INC. | $51.37 | 2024-2025 | Cimerli |
| Bausch & Lomb Americas INC. | $47.80 | 2022-2024 | Vyzulta, Xiidra, Miebo |
| Mallinckrodt Hospital Products INC. | $45.80 | 2021 | |
| Ani Pharmaceuticals, INC. | $45.61 | 2025 | Purified Cortrophin Gel, Yutiq |
| Apellis Pharmaceuticals, INC. | $42.57 | 2023-2024 | Syfovre |
| Rayner Intraocular Lenses Limited | $38.44 | 2023-2024 | Omidria, Rayone Spheric, Rayone Emv |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $37.90 | 2025 | Eylea Hd |
| Omeros Corporation | $33.40 | 2019-2021 | |
| Astellas Pharma US INC | $19.23 | 2025 | Izervay |
| Thea Pharma INC. | $18.87 | 2025 | Iyuzeh |
| Rxsight INC | $18.80 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Light Adjustable Lens (Rxlal) |
| Tarsus Pharmaceuticals, INC. | $18.55 | 2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $17.92 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.